Retatrutide
FDA approvedTriple agonist — three receptors, one molecule, the highest weight loss efficacy ever recorded.
Mechanism
GLP-1 / GIP / glucagon triple agonist. Triple agonist — three receptors, one molecule, the highest weight loss efficacy ever recorded. For full mechanism, dosing protocol, and stacking guidance, ask the AI Advisor or open the compound in-app.
Peer-Reviewed Studies (3)
Triple-Hormone-Receptor Agonist Retatrutide for Obesity — Phase 2
24.2% weight loss at 48 weeks; 26% lost ≥25%.
PubMed PMID 37351564 →Retatrutide for Type 2 Diabetes — Phase 2
HbA1c reduction of 2.02% with 16.94% weight loss.
PubMed PMID 37385280 →Retatrutide and MASLD Liver Fat — Phase 2
>80% relative liver fat reduction at 48 weeks.
PubMed PMID 38641750 →